| Pharmaceutical active ingredients: |
| Simethicone |
| Available forms, composition and doses of Phazyme Maximum Strength: |
| Capsules; Oral; Simethicone 166 mg |
| Phazyme Maximum Strength medical category: |
| Human:Antacids and adsorbentsAntiflatulentsGIT regulators, antiflatulents and anti-inflammatories |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A03AX13 - Silicones |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Phasicon | Ethinyl Estradiol; Lynestrenol | Organon |
| Phatropine | Benztropine Mesylate | Pharmaland 1982 |
| Phavic-1 | Nitazoxanide | Unidentified Pharmaceutical Company |
| Phazyme | Simethicone | GlaxoSmithKline; Stafford Miller |
| Phazyme Infant Drops | Dimethicone | GlaxoSmithKline; Reed & Carnrick |
| Phazyme-PB | Phenobarbital; Simethicone | GlaxoSmithKline; Schwarz Pharma |
| PH-Cool | Magaldrate; Oxetacaine; Simethicone | Peerage Pharma |
| PHD Germicidal Disinfectant and Deodorant | Benzalkonium Chloride; Didecyl Dimethyl Ammonium Chloride | Pioneer Eclipse Corporation |
| PH-Derm | Barrier Preparation; Emollients; Skin Cleansers | Mediphar |
| Phebrocon | Cetylpyridinium Chloride; Dequalinium Undecenoate; Hexylresorcinol | Merz |